Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12060356 7 (methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives

Patent 12060356 was granted and assigned to Eli Lilly and Company on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120603560

Patent Inventor Names

Theodore Curtis Jessop0

Zhaogen Chen0

Date of Patent

August 13, 2024

Patent Application Number

173114060

Date Filed

December 4, 2019

Patent Citations

‌

US Patent 11891400 Pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful in the treatment of psoriasis and systemic lupus erythematosus

‌

US Patent 11634423 Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of interferon signaling

‌

US Patent 7557110 Pyrazolo[1,5-A] pyrimidine derivatives

‌

US Patent 7645762 Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors

‌

US Patent 8637526 Pyrazolopyrimidine JAK inhibitor compounds and methods

‌

US Patent 8921380 Pyrazolo[1,5-a] pyrimidine compounds as CB1 receptor antagonist

‌

US Patent 10273237 Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12060356 7 (methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API